Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an announcement.
Shanghai Haohai Biological Technology Co., Ltd. announced that one of its controlling shareholders, Mr. Jiang Wei, has been notified by the China Securities Regulatory Commission (CSRC) regarding a case filing for suspected insider trading. The company clarified that this investigation is personal to Mr. Jiang Wei and does not involve the company’s shares or affect its daily operations. The company will continue to monitor the situation and fulfill its disclosure obligations.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in China, focusing on the biotechnology sector. The company is listed on the Hong Kong Stock Exchange and is involved in the development and production of biological products.
Average Trading Volume: 579,936
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.09B
Find detailed analytics on 6826 stock on TipRanks’ Stock Analysis page.